Safety and Feasibility Evaluation of the APS APP

NCT03504046 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sansum Diabetes Research Institute

Collaborators